Literature DB >> 12210417

Detection of human herpesvirus 8 DNA in serum from blood donors with HHV-8 antibodies indicates possible bloodborne virus transmission.

Malin Enbom1, Willy Urassa, Charles Massambu, Rigmor Thorstensson, Fred Mhalu, Annika Linde.   

Abstract

Human herpesvirus 8 (HHV-8) is associated with Kaposi's sarcoma. There is a high seroprevalence of HHV-8 in several African countries, but the transmission route is not known definitively. In this study 174 serum samples from blood donors in Tanzania were examined by immunofluorescence assays detecting antibodies to latent and lytic HHV-8 antigens. Real-time polymerase chain reaction was used for detection and quantification of HHV-8 DNA in serum. In all, 83/174 (48%) of the subjects had antibodies to latent or lytic antigens. Forty (23%) had antibodies to both antigens and of those eight (20%) had detectable HHV-8 DNA in serum. HHV-8 DNA load correlated with antibody titres to lytic, but not latent, HHV-8 antigens. This supports the usefulness of anti-lytic antibodies in HHV-8 serology and suggests that transmission of HHV-8 by blood contact could be of importance in this region. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210417     DOI: 10.1002/jmv.10183

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.

Authors:  Angela Nalwoga; Marjorie Nakibuule; Vickie Marshall; Wendell Miley; Nazzarena Labo; Stephen Cose; Denise Whitby; Robert Newton
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

2.  AIDS and non AIDS-related malignant lymphoma in Tanzania.

Authors:  Ephata E Kaaya; Esmeralda Castaños-Velez; Marianne Ekman; Amos Mwakigonja; Primo Carneiro; Leonard Lema; James Kitinya; Anika Linde; Peter Biberfeld
Journal:  Afr Health Sci       Date:  2006-06       Impact factor: 0.927

Review 3.  Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.

Authors:  Evan M Bloch; Marion Vermeulen; Edward Murphy
Journal:  Transfus Med Rev       Date:  2011-08-26

Review 4.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

5.  Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions.

Authors:  José Eduardo Levi; Maria Claudia Nascimento; Laura Masami Sumita; Vanda Akico Ueda Fick de Souza; Wilton S Freire; Philippe Mayaud; Claudio S Pannuti
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

6.  Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions.

Authors:  Amos R Mwakigonja; Pawan Pyakurel; Parviz Kokhaei; Fatemeh Pak; Leonard K Lema; Ephata E Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2008-06-30       Impact factor: 2.965

7.  No Evidence of Human Herpesvirus 8 among Iranian Patients Infected with HIV.

Authors:  Amitis Ramezani; Elham Saboori; Kayhan Azadmanesh; Minoo Mohraz; Monireh Kazemimanesh; Afsaneh Karami; Mohammad Banifazl; Hanieh Golchehregan; Arezoo Aghakhani
Journal:  Iran J Public Health       Date:  2016-07       Impact factor: 1.429

8.  Prevalence of Kaposi's sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China.

Authors:  Jun Zheng; Yang Yang; Meng Cui; Zhan-Jun Shu; Li-Li Han; Zhen-Qiu Liu; Charles Wood; Tiejun Zhang; Yan Zeng
Journal:  Virol Sin       Date:  2017-10-25       Impact factor: 4.327

Review 9.  Emerging infections in transfusion medicine.

Authors:  Eberhard W Fiebig; Michael P Busch
Journal:  Clin Lab Med       Date:  2004-09       Impact factor: 1.935

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.